I'd love to see licensing as JDP has stated, however, I can't see it being appealing to pharma at the same time as financially beneficial to RAC.
One of the speculations I've thrown around to a few people is that RAC will organise a loan structure. If only there were someone with enough conviction, and deep enough pockets to loan a measly few mill to RAC....
Ann: Race Strategic Update August 2023, page-574
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.68 | $1.61 | $118.5K | 72.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 601 | 1 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |